| High-speed and scalable whole-brain imaging in rodents and primates K Seiriki, A Kasai, T Hashimoto, W Schulze, M Niu, S Yamaguchi, ... Neuron 94 (6), 1085-1100. e6, 2017 | 122 | 2017 |
| Abnormal phospholipids distribution in the prefrontal cortex from a patient with schizophrenia revealed by matrix-assisted laser desorption/ionization imaging mass spectrometry J Matsumoto, Y Sugiura, D Yuki, T Hayasaka, N Goto-Inoue, N Zaima, ... Analytical and bioanalytical chemistry 400, 1933-1943, 2011 | 70 | 2011 |
| Investigation of betaine as a novel psychotherapeutic for schizophrenia T Ohnishi, S Balan, M Toyoshima, M Maekawa, H Ohba, A Watanabe, ... EBioMedicine 45, 432-446, 2019 | 53 | 2019 |
| Assessment of copy number variations in the brain genome of schizophrenia patients M Sakai, Y Watanabe, T Someya, K Araki, M Shibuya, K Niizato, ... Molecular cytogenetics 8, 1-9, 2015 | 50 | 2015 |
| Trends in big data analyses by multicenter collaborative translational research in psychiatry T Onitsuka, Y Hirano, K Nemoto, N Hashimoto, I Kushima, D Koshiyama, ... Psychiatry and clinical neurosciences 76 (1), 1-14, 2022 | 45 | 2022 |
| Association between the superior longitudinal fasciculus and perceptual organization and working memory: A diffusion tensor imaging study D Koshiyama, M Fukunaga, N Okada, K Morita, K Nemoto, F Yamashita, ... Neuroscience Letters 738, 135349, 2020 | 41 | 2020 |
| Downregulation of GNA13-ERK network in prefrontal cortex of schizophrenia brain identified by combined focused and targeted quantitative proteomics M Hirayama-Kurogi, Y Takizawa, Y Kunii, J Matsumoto, A Wada, M Hino, ... Journal of proteomics 158, 31-42, 2017 | 41 | 2017 |
| Decreased VEGFR2 expression and increased phosphorylated Akt1 in the prefrontal cortex of individuals with schizophrenia M Hino, Y Kunii, J Matsumoto, A Wada, A Nagaoka, S Niwa, H Takahashi, ... Journal of psychiatric research 82, 100-108, 2016 | 36 | 2016 |
| Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: real-world evidence from the Effectiveness of Guidelines for … N Hashimoto, N Yasui-Furukori, N Hasegawa, S Ishikawa, S Numata, ... Asian Journal of Psychiatry 63, 102744, 2021 | 32 | 2021 |
| Prescription patterns in patients with schizophrenia in Japan: first‐quality indicator data from the survey of “Effectiveness of Guidelines for Dissemination and Education in … K Ichihashi, H Hori, N Hasegawa, Y Yasuda, T Yamamoto, T Tsuboi, ... Neuropsychopharmacology reports 40 (3), 281-286, 2020 | 32 | 2020 |
| Neuroimaging studies within Cognitive Genetics Collaborative Research Organization aiming to replicate and extend works of ENIGMA D Koshiyama, K Miura, K Nemoto, N Okada, J Matsumoto, M Fukunaga, ... Human brain mapping 43 (1), 182-193, 2022 | 31 | 2022 |
| Mental disorders that exacerbated due to the F ukushima disaster, a complex radioactive contamination disaster J Matsumoto, Y Kunii, A Wada, H Mashiko, H Yabe, S Niwa Psychiatry and Clinical Neurosciences 68 (3), 182-187, 2014 | 28 | 2014 |
| Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium D Schijven, MC Postema, M Fukunaga, J Matsumoto, K Miura, ... Proceedings of the National Academy of Sciences 120 (14), e2213880120, 2023 | 25 | 2023 |
| Unmet needs of patients with major depressive disorder–Findings from the ‘E ffectiveness of G uidelines for D issemination and E ducation in P sychiatric T reatment (EGUIDE … H Iida, J Iga, N Hasegawa, Y Yasuda, T Yamamoto, K Miura, J Matsumoto, ... Psychiatry and clinical neurosciences 74 (12), 667-669, 2020 | 25 | 2020 |
| Decreased 16: 0/20: 4-phosphatidylinositol level in the post-mortem prefrontal cortex of elderly patients with schizophrenia J Matsumoto, H Nakanishi, Y Kunii, Y Sugiura, D Yuki, A Wada, M Hino, ... Scientific reports 7 (1), 45050, 2017 | 20 | 2017 |
| Genetics of autism spectrum disorders and future direction Y Yasuda, J Matsumoto, K Miura, N Hasegawa, R Hashimoto Journal of Human Genetics 68 (3), 193-197, 2023 | 19 | 2023 |
| Association between the examination rate of treatment‐resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study N Yasui‐Furukori, H Muraoka, N Hasegawa, S Ochi, S Numata, H Hori, ... Neuropsychopharmacology reports 42 (1), 3-9, 2022 | 19 | 2022 |
| Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study R Furihata, R Otsuki, N Hasegawa, T Tsuboi, S Numata, N Yasui-Furukori, ... Sleep Medicine 89, 23-30, 2022 | 18 | 2022 |
| Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study S Numata, M Nakataki, N Hasegawa, Y Takaesu, M Takeshima, ... Neuropsychopharmacology reports 41 (2), 199-206, 2021 | 18 | 2021 |
| Differential protein expression of DARPP-32 versus Calcineurin in the prefrontal cortex and nucleus accumbens in schizophrenia and bipolar disorder Y Kunii, M Hino, J Matsumoto, A Nagaoka, H Nawa, A Kakita, H Akatsu, ... Scientific reports 9 (1), 14877, 2019 | 17 | 2019 |
Yasuto KuniiDepartment of Disaster Psychiatry, International Research Institute of Disaster Science, Tohoku在 tohoku.ac.jp 的电子邮件经过验证
